年別の研究成果
年別の研究成果
検索結果
-
2022
Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’: [ESMO Open Volume 6, Issue 4, August 2021, 100191] (ESMO Open (2021) 6(4), (S2059702921001526), (10.1016/j.esmoop.2021.100191))
Hotta, K., Saeki, S., Yamaguchi, M., Harada, D., Bessho, A., Tanaka, K., Inoue, K., Gemba, K., Shiojiri, M., Kato, Y., Ninomiya, T., Kubo, T., Kishimoto, J., Shioyama, Y., Katsui, K., Sasaki, J., Kiura, K. & Sugio, K., 8月 2022, In: ESMO Open. 7, 4, 100532.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
-
2017
Corrigendum to “Thymic epithelial cell-specific deletion of Jmjd6 reduces aire protein expression and exacerbates disease development in a mouse model of autoimmune diabetes” [Biochemical and Biophysical Research Communications 489/1 (2017) 8–13] (S0006291X1730997X) (10.1016/j.bbrc.2017.05.113)
Yanagihara, T., Tomino, T., Uruno, T. & Fukui, Y., 9月 30 2017, In: Biochemical and Biophysical Research Communications. 491, 4, p. 1126 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
-
2014
Corrigendum to "Genetic polymorphisms involved in the inflammatory response and lung cancer risk: A case-control study in Japan" [Cytokine 2014; 65:88-94]
Kiyohara, C., Horiuchi, T., Takayama, K. & Nakanishi, Y., 9月 2014, In: Cytokine. 69, 1, p. 154 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読